Biotech | May 06, 2022
Biogen and MedRhythms partner for digital therapeutic targeting the treatment of gait deficits in multiple sclerosis
The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)